📖

Antisense Oligonucleotide Therapy for C9orf72 ALS/FTD

wiki page Created: 2026-04-02T20:40:08 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-therapeutics-aso-c9orf72-als
Related Entities
therapeutics-aso-c9orf72-als
🌍 Provenance Graph 1 nodes, 0 edges

No provenance edges found

📊 Evidence Profile
Evidence Balance
+0%
Certainty
100%
Debates
0
Incoming
84
Outgoing
86
0 supporting 0 contradicting 0 neutral
View full evidence profile →
Linked Artifacts (170)
related🧪Bacterial Enzyme-Mediated Dopamine Precursor Synthesis90%
mentions🧪Bacterial Enzyme-Mediated Dopamine Precursor Synthesis90%
related🧫Glymphatic-Circadian Axis Enhancement Therapy for Parkinson&70%
related🧫Oligodendrocyte-Myelin Dysfunction Validation in Parkinson&#70%
related🧫Endocannabinoid System Dysfunction Validation in Parkinson&#70%
related🧫Progranulin Replacement Therapy for FTD — Vector Development70%
related🧫Mechanism: C9orf72 Hexanucleotide Repeat Expansion in ALS/FT70%
related🧫Mechanism: C9orf72 Hexanucleotide Repeat Expansion in ALS/FT70%
related🧫Purinergic Signaling Dysfunction Validation in Parkinson70%
related🧫Experiment Validation: In vitro ThT Assay70%
related🧫Experiment Validation: In vitro ThT Assay70%
related🧫ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De70%
related🧫Oligodendrocyte-Myelin Dysfunction Validation in Parkinson&#70%
related🧫Proteasome-Ubiquitin System Dysfunction Validation in Parkin70%
related🧫Regulated Necrosis Validation Study in Parkinson's Dise70%
related🧫FTD Microglia Role: Protective vs Destructive Mechanism Stud70%
related🧫Gut Microbiome-Derived Metabolites in Alpha-Synuclein Propag70%
related🧫ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De70%
related🧫C9orf72 Phenotype Divergence: ALS vs FTD Mechanism Study70%
related🧫C9orf72 Phenotype Divergence: ALS vs FTD Mechanism Study70%
related🧫Autophagy Enhancement Drug Screening for Neurodegeneration70%
related🧫Protein Aggregation Kinetic Validation Results70%
related🧫Animal Model Comparison for Neurodegenerative Disease Therap70%
related🧫Purinergic Signaling Dysfunction Validation in Parkinson70%
related🧫Proteasome-Ubiquitin System Dysfunction Validation in Parkin70%
related🧫Autophagy Enhancement Drug Screening for Neurodegeneration70%
related🧫Endocannabinoid System Dysfunction Validation in Parkinson&#70%
related🧫Frontal and Temporal Lobe Selective Vulnerability in FTD — M70%
related🧫Stress Granule Dysfunction Validation in Parkinson's Di70%
related🧫Neural Oscillation Dysfunction Validation in Parkinson'70%
related🧫Animal Model Comparison for Neurodegenerative Disease Therap70%
related🧫Protein Aggregation Kinetic Validation Results70%
related🧫Gut Microbiome-Derived Metabolites in Alpha-Synuclein Propag70%
related🧫Progranulin Replacement Therapy for FTD — Vector Development70%
related🧫Glymphatic-Circadian Axis Enhancement Therapy for Parkinson&70%
related🧫Stress Granule Dysfunction Validation in Parkinson's Di70%
related🧫FTD Microglia Role: Protective vs Destructive Mechanism Stud70%
related🧫Neural Oscillation Dysfunction Validation in Parkinson'70%
related🧫Regulated Necrosis Validation Study in Parkinson's Dise70%
related🧫Frontal and Temporal Lobe Selective Vulnerability in FTD — M70%
mentions🔬CRISPR-based therapeutic approaches for neurodegenerative di60%
related🧫Sporadic ALS Initiation Biology: Deep Phenotyping of At-Risk60%
related🧫ALS Progression Rate Heterogeneity — mechanism and biomarker60%
related🧫s:** - Single-cell RNA-seq to measure editing efficiency acr60%
related🧫Environmental Exposure Causal Attribution in ALS — Experimen60%
mentions🔬RNA binding protein dysregulation across ALS FTD and AD60%
related🧫Pre-Symptomatic Tau Detection in MAPT Mutation Carriers60%
mentions🔬How do non-cell autonomous effects of autophagy dysfunction 60%
related🧫Metabolic Pathway-Targeted Therapy in ALS60%
related🧫PSP and CBS Biomarker Validation Study60%
related🧫Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri60%
related🧫Microbiome-Gut Barrier Signatures in ALS — Experiment Design60%
related🧫FXTAS Phenotypic Penetrance: Why Only 40% of FMR1 Premutatio60%
mentions🔬RNA binding protein dysregulation across ALS FTD AD60%
related🧫Blood Biomarker vs Tau PET for Treatment Monitoring60%
related🧫Mechanism: Progranulin Loss and TDP-43 Pathology in FTD60%
mentions🔬What are the mechanisms underlying tdp-43 phase separation t60%
related🧫ALS Regional Onset and Spread: Network-Level Staging Model60%
related🧫Sleep and Respiratory Network Interaction in ALS — Experimen60%
mentions🔬Analyze the spectrum of microglial activation states (DAM, h60%
mentions🔬CRISPR-based therapeutic approaches for neurodegenerative di60%
related🧫TDP-43 PET Ligand Development for FTD and ALS60%
related🧫Pre-Symptomatic Detection and Intervention Timing in Genetic60%
related🧫Brainstem Circuit Modulation for PSP60%
mentions🔬What are the mechanisms underlying rna binding protein dysre60%
related🧫N-of-1 Clinical Trial Design for CBS/PSP60%
related🧫Viral and Post-Infectious Mechanisms in ALS — Experiment Des60%
mentions🔬TDP-43 undergoes liquid-liquid phase separation that becomes60%
related🧫TDP-43 PET Ligand Development for FTD and ALS54%
related🔬RNA binding protein dysregulation across ALS FTD and AD54%
related🧫Sporadic ALS Initiation Biology: Deep Phenotyping of At-Risk54%
related🧫N-of-1 Clinical Trial Design for CBS/PSP54%
related🔬CRISPR-based therapeutic approaches for neurodegenerative di54%
related🧫Pre-Symptomatic Tau Detection in MAPT Mutation Carriers54%
related🔬What are the mechanisms underlying tdp-43 phase separation t54%
related🧫Microbiome-Gut Barrier Signatures in ALS — Experiment Design54%
related🧫Viral and Post-Infectious Mechanisms in ALS — Experiment Des54%
related🧫Environmental Exposure Causal Attribution in ALS — Experimen54%
related🧫Mechanism: Progranulin Loss and TDP-43 Pathology in FTD54%
related🧫Sleep and Respiratory Network Interaction in ALS — Experimen54%
related🔬TDP-43 undergoes liquid-liquid phase separation that becomes54%
related🔬Analyze the spectrum of microglial activation states (DAM, h54%
related🧫Metabolic Pathway-Targeted Therapy in ALS54%
related🧫FXTAS Phenotypic Penetrance: Why Only 40% of FMR1 Premutatio54%
related🔬What are the mechanisms underlying rna binding protein dysre54%
related🔬RNA binding protein dysregulation across ALS FTD AD54%
related🧫PSP and CBS Biomarker Validation Study54%
related🧫Blood Biomarker vs Tau PET for Treatment Monitoring54%
related🧫s:** - Single-cell RNA-seq to measure editing efficiency acr54%
related🔬CRISPR-based therapeutic approaches for neurodegenerative di54%
related🧫ALS Regional Onset and Spread: Network-Level Staging Model54%
related🧫Pre-Symptomatic Detection and Intervention Timing in Genetic54%
related🧫Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri54%
related🧫ALS Progression Rate Heterogeneity — mechanism and biomarker54%
related🔬How do non-cell autonomous effects of autophagy dysfunction 54%
related🧫Brainstem Circuit Modulation for PSP54%
mentions🧪Selective Acid Sphingomyelinase Modulation Therapy50%
mentions🧪Lysosomal Calcium Channel Modulation Therapy50%
related🔬What are the mechanisms underlying sleep disruption as cause50%
related🔬What are the mechanisms underlying sleep disruption as cause50%
related🔬What are the mechanisms underlying tdp-43 phase separation t50%
related🔬What are the mechanisms underlying apoe4 structural biology 50%
related🔬Investigate how lipid raft composition (cholesterol metaboli50%
mentions🧪Complement C1q Mimetic Decoy Therapy50%
related🔬What are the mechanisms underlying synaptic pruning by micro50%
related🔬What are the mechanisms underlying mitochondrial transfer be50%
mentions🧪Gamma entrainment therapy to restore hippocampal-cortical sy50%
related🔬What are the mechanisms underlying neuroinflammation resolut50%
mentions🧪CYP46A1 Overexpression Gene Therapy50%
mentions🧪PARP1 Inhibition Therapy50%
related🔬What are the mechanisms underlying autophagy-lysosome pathwa50%
related🔬Analyze circuit-level changes in neurodegeneration using All50%
mentions🧪Targeted APOE4-to-APOE3 Base Editing Therapy50%
related🔬What are the mechanisms underlying selective vulnerability o50%
mentions🧪Purinergic P2Y12 Inverse Agonist Therapy50%
mentions🧪Circadian Glymphatic Rescue Therapy (Melatonin-focused)50%
related🔬What are the mechanisms underlying epigenetic clocks and bio50%
mentions🧪Orexin-Microglia Modulation Therapy50%
related🔬What are the mechanisms underlying autophagy-lysosome pathwa50%
related🔬What are the mechanisms underlying rna binding protein dysre50%
related🔬What are the mechanisms underlying synaptic pruning by micro50%
related🔬Analyze circuit-level changes in neurodegeneration using All50%
related🔬What are the mechanisms underlying 4r-tau strain-specific sp50%
mentions🧪TET2-Mediated Demethylation Rejuvenation Therapy50%
mentions🧪Glial Glycocalyx Remodeling Therapy50%
mentions🧪Arginine Methylation Enhancement Therapy50%
mentions🧪SIRT6-NAD+ Axis Enhancement Therapy50%
related🔬What are the mechanisms underlying blood-brain barrier trans50%
mentions🧪HCN1-Mediated Resonance Frequency Stabilization Therapy50%
mentions🧪DNMT1-Targeting Antisense Oligonucleotide Reset50%
related🔬Investigate how lipid raft composition (cholesterol metaboli50%
related🔬What are the mechanisms underlying epigenetic clocks and bio50%
mentions🧪Ganglioside Rebalancing Therapy50%
related🔬What are the mechanisms underlying what are the mechanisms b50%
related🔬What are the mechanisms underlying senolytic therapy for age50%
related🔬How to break the GBA-alpha-synuclein bidirectional loop for 50%
related🔬What are the mechanisms underlying mitochondrial transfer be50%
mentions🧪Hypocretin-Neurogenesis Coupling Therapy50%
mentions🧪R-Loop Resolution Enhancement Therapy50%
related🔬What are the mechanisms underlying what are the mechanisms b50%
mentions🧪Near-infrared light therapy stimulates COX4-dependent mitoch50%
related🔬What are the mechanisms underlying neuroinflammation resolut50%
related🔬What are the mechanisms underlying apoe4 structural biology 50%
mentions🧪Astrocytic Lipoxin A4 Pathway Restoration via ALOX15 Gene Th50%
related🧪CYP46A1 Overexpression Gene Therapy40%
related🧪PARP1 Inhibition Therapy40%
related🧪Orexin-Microglia Modulation Therapy40%
related🧪Glial Glycocalyx Remodeling Therapy40%
related🧪R-Loop Resolution Enhancement Therapy40%
mentions🔬What are the mechanisms underlying blood-brain barrier trans40%
related🧪Complement C1q Mimetic Decoy Therapy40%
related🧪Lysosomal Calcium Channel Modulation Therapy40%
mentions🔬How to break the GBA-alpha-synuclein bidirectional loop for 40%
related🧪Selective Acid Sphingomyelinase Modulation Therapy40%
related🧪HCN1-Mediated Resonance Frequency Stabilization Therapy40%
related🧪TET2-Mediated Demethylation Rejuvenation Therapy40%
related🧪Astrocytic Lipoxin A4 Pathway Restoration via ALOX15 Gene Th40%
related🧪Near-infrared light therapy stimulates COX4-dependent mitoch40%
related🧪SIRT6-NAD+ Axis Enhancement Therapy40%
related🧪Hypocretin-Neurogenesis Coupling Therapy40%
related🧪Targeted APOE4-to-APOE3 Base Editing Therapy40%
related🧪Circadian Glymphatic Rescue Therapy (Melatonin-focused)40%
related🧪Ganglioside Rebalancing Therapy40%
mentions🔬What are the mechanisms underlying senolytic therapy for age40%
related🧪Arginine Methylation Enhancement Therapy40%
related🧪Gamma entrainment therapy to restore hippocampal-cortical sy40%
related🧪Purinergic P2Y12 Inverse Agonist Therapy40%
related🧪DNMT1-Targeting Antisense Oligonucleotide Reset40%
related🔬What are the mechanisms underlying selective vulnerability o30%
related🔬What are the mechanisms underlying 4r-tau strain-specific sp30%

💬 Discussion